References
- Baird, D. T. (1987). A model for follicular selection and ovulation: lessons from superovulation. Journal of Steroid Biochemistry, 27, 15–23.
- Balen, A. H., Anderson, R. A. (2007). Impact of obesity on female reproductive health: British Fertility Society Policy and Practice Guidelines. Human Fertility, 10, 195–206.
- Balen, A. H., Platteau, P., Andersen, A. N., Devroey, P., Sorensen, P., Helmgaard, L., et al (2006). The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility. British Journal of Obstetrics & Gynaecology, 113, 1193–1202.
- Dickey, R. P. (2009). Strategies to reduce multiple pregnancies due to ovulation stimulation. Fertility & Sterility, 91, 1–17.
- Erel, C. T., Senturk, L. M. (2009). The impact of body mass index on assisted reproduction. Current Opinion in Obstetrics & Gynecology, 21, 228–235.
- Gorry, A., White, D. M., Franks, S. (2006). Infertility in polycystic ovary syndrome: focus on low-dose gonadotropin treatment. Endocrine, 30, 27–33.
- Guido, M., Belosi, C., Selvaggi, L., Lattanzi, F., Apa, R., Fulghesu, A. M., et al (2003). The effect of age on the ovarian response to gonadotropin and on pregnancy rate in polycystic ovary syndrome. Gynecological Endocrinology, 17, 215–221.
- Homburg, R. (2005). Clomiphene citrate – end of an era? A mini-review. Human Reproduction, 20, 2043–2051.
- Homburg, R., Howles, C. M. (1999). Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements. Human Reproduction Update, 5, 493–499.
- Kousta, E., White, D. M., Franks, S. (1997). Modern use of clomiphene citrate in induction of ovulation. Human Reproduction Update, 3, 359–365.
- Mulders, A. (2003). Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility. Reproductive Biomedicine Online, 7, 170–178.
- Mulders, A. G. M. G. J., Laven, J. S. E., Eijkemans, M. J. C., Hughes, E. G., Fauser, B. C. J. M. (2003). Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis. Human Reproduction Update, 9, 429–449.
- Templeton, A., Morris, J. K., Parslow, W. (1996). Factors that affect outcome of in-vitro fertilisation treatment. Lancet, 348, 1402–1406.
- The Practice Committee of the American Society for Reproductive Medicine. (2008a). Obesity and reproduction: an educational bulletin. Fertility & Sterility, 90(Suppl 3), S21–S29.
- The Practice Committee of the American Society for Reproductive Medicine. (2008b). Use of exogenous gonadotrophins in anovulatory women: a technical bulletin. Fertility & Sterility, 90(Suppl 3), S7–S12.
- The Rotterdam ESHRE/ASRM-Sposored PCOS Consensus Workshop Group. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction, 19, 41–47.
- The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2008). Consensus on infertility treatment related to polycystic ovary syndrome. Human Reproduction, 23, 462–477.
- Van Wely, M., Bayram, N., van der Veen, F., Bossuyt, P. M. M. (2005). Predicting ongoing pregnancy following ovulation induction with recombinant FSH in women with polycystic ovary syndrome. Human Reproduction, 20, 1827–1832.